Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Tricida Inc. TCDA

Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.


Top institutional share ownership of Tricida Inc

Name Shares Shares % change Value Value % change
Orbimed Advisors Llc 10,280,947 0.0% $99,520 17.8%
VR Adviser, LLC 7,132,079 58.7% $69,039 86.9%
Deep Track Capital, LP 2,732,117 3.0% $26,447 21.3%
BlackRock Inc. 2,688,493 178.4% $26,023 227.9%
Frazier Life Sciences Management, L.P. 2,082,093 0.0% $20,155 17.8%
Commodore Capital Lp 2,028,453 16.3% $19,635 36.9%
Lion Point Capital, LP 1,826,729 0.0% $12,034 -19.9%
Vanguard Group Inc 1,603,280 12.0% $15,519 31.9%
Baker Bros. Advisors Lp 1,503,090 -13.2% $14,550 2.2%
Stonehill Capital Management Llc 1,436,736 -1.9% $13,908 15.6%

Top institutional buyers of Tricida Inc

Name Shares % change Value % change Shares Value
State Street Corp 415.5% 507.0% 547,419 $5,299
BlackRock Inc. 178.4% 227.9% 2,688,493 $26,023
Geode Capital Management, Llc 95.1% 129.7% 606,893 $5,874
Tri Locum Partners LP 70.3% 100.5% 731,142 $7,077
VR Adviser, LLC 58.7% 86.9% 7,132,079 $69,039
USSCX - Science & Technology Fund Shares 54.5% 40.5% 310,309 $2,864
Two Sigma Advisers, Lp 26.0% 48.4% 359,300 $3,478
Commodore Capital Lp 16.3% 36.9% 2,028,453 $19,635
Vanguard Group Inc 12.0% 31.9% 1,603,280 $15,519
VEXMX - Vanguard Extended Market Index Fund Investor Shares 9.1% 28.5% 447,813 $4,335

Top institutional sellers of Tricida Inc

Name Shares % change Value % change Shares Value
Point72 Asset Management, L.P. -64.2% -57.8% 657,400 $6,364
Bleichroeder LP -62.5% -55.8% 450,000 $4,356
D. E. Shaw & Co., Inc. -27.9% -15.1% 526,336 $5,095
Baker Bros. Advisors Lp -13.2% 2.2% 1,503,090 $14,550
Great Point Partners Llc -6.8% 9.7% 1,164,763 $11,275
Stonehill Capital Management Llc -1.9% 15.6% 1,436,736 $13,908
IWM - iShares Russell 2000 ETF -1.4% 80.5% 699,790 $6,774

Information provided by Fintel.io